Guangzhou Baiyunshan Pharmaceutical Holdings (00874) branch received the Drug Registration Certificate for Sorafenib Tosylate Tablets
Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced that recently, its branch, the Baiyunshan Pharmaceutical General Factory of Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd., received the Drug Registration Certificate for Sorafenib Tosylate Tablets approved and issued by the National Medical Products Administration.
Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced that recently, the company's branch, the General Pharmaceutical Factory of Guangzhou Baiyunshan Pharmaceutical Holdings Pharmaceutical Group Co., Ltd., received the Drug Registration Certificate for Sorafenib Tosylate Tablets approved and issued by the National Medical Products Administration.
The obtaining of the Drug Registration Certificate for Sorafenib Tosylate Tablets by the General Pharmaceutical Factory of Guangzhou Baiyunshan Pharmaceutical Holdings this time has enriched the variety of anti-tumor drugs and is conducive to improving the company's product layout in the field of tumor treatment. The General Pharmaceutical Factory of Guangzhou Baiyunshan Pharmaceutical Holdings will carry out production in accordance with relevant requirements and market demand.
Related Articles
YUM CHINA (09987) repurchased approximately 71,000 shares for approximately US$3.1613 million on October 28.
SUNSHINE 100 (02608): Han Bin and Yu Anni Resign as Joint Company Secretaries
MNSO (09896) repurchased 100,000 shares on October 29 for HK$1.904 million.
YUM CHINA (09987) repurchased approximately 71,000 shares for approximately US$3.1613 million on October 28.
SUNSHINE 100 (02608): Han Bin and Yu Anni Resign as Joint Company Secretaries
MNSO (09896) repurchased 100,000 shares on October 29 for HK$1.904 million.
